Rezultati - Cutter, Gary

Mammography Screening and Differences in Stage of Disease by Race/Ethnicity od Jacobellis, Jillian, Cutter, Gary

Polni tekst Polni tekst

Personalized medicine: The return of the house call? od Cutter, Gary R., Liu, Yuliang

Polni tekst Polni tekst Polni tekst

Cost-effectiveness analyses: Beauty and the beast? od Cutter, Gary R., Wang, Guoqiao

Polni tekst Polni tekst Polni tekst

To treat or not to treat, that really is not the question od Wang, Guoqiao, Cutter, Gary R.

Polni tekst Polni tekst Polni tekst

Long-term registries: Answering tough questions with big data? od Fox, Robert J., Cutter, Gary

Polni tekst Polni tekst Polni tekst

Response from Findley, et al od Findley, Mike, Rose, Vernon, Cutter, Gary

Polni tekst

If Thymectomy Reduces the Risk of Progression of Ocular to Generalized Myasthenia Gravis, Who Should Receive it? od Cutter, Gary R., Sanders, Donald B.

Polni tekst Polni tekst Polni tekst

Item response theory-based measure of global disability in multiple sclerosis derived from the Performance Scales and related items od Chamot, Eric, Kister, Ilya, Cutter, Gary R

Polni tekst Polni tekst Polni tekst

How Multiple Sclerosis Symptoms Vary by Age, Sex, and Race/Ethnicity od Kister, Ilya, Bacon, Tamar, Cutter, Gary R.

Polni tekst Polni tekst Polni tekst

Arteriovenous Fistula Nonmaturation: What’s the Immune System Got to Do with It? od Farrington, Crystal A., Cutter, Gary, Allon, Michael

Polni tekst Polni tekst Polni tekst

Inferences and Power Analysis Concerning Two Negative Binomial Distributions with An Application to MRI Lesion Counts Data od Aban, Inmaculada B., Cutter, Gary R., Mavinga, Nsoki

Polni tekst Polni tekst Polni tekst

Requiring an amyloid-β(1-42) biomarker for prodromal Alzheimer’s disease or mild cognitive impairment does not lead to more efficient clinical trials od Schneider, Lon S., Kennedy, Richard E., Cutter, Gary R.

Polni tekst Polni tekst Polni tekst

Effect of APOE Genotype Status on Targeted Clinical Trials Outcomes and Efficiency in Dementia and MCI due to AD od Kennedy, Richard E., Cutter, Gary R., Schneider, Lon S.

Polni tekst Polni tekst Polni tekst

Which symptoms contribute the most to patients’ perception of health in multiple sclerosis? od Green, Rivka, Cutter, Gary, Friendly, Michael, Kister, Ilya

Polni tekst Polni tekst Polni tekst

Clinical trials in multiple sclerosis: milestones od Zhang, Yinan, Salter, Amber, Cutter, Gary, Stuve, Olaf

Polni tekst Polni tekst Polni tekst

Short-term disability progression in two multiethnic multiple sclerosis centers in the treatment era od Kister, Ilya, Bacon, Tamar E., Cutter, Gary R.

Polni tekst Polni tekst Polni tekst

A cross-sectional study of bone health in multiple sclerosis od Marrie, Ruth Ann, Cutter, Gary, Tyry, Tuula, Vollmer, Timothy

Polni tekst Polni tekst Polni tekst

Cumulative Impact of Comorbidity on Quality of Life in MS od Marrie, Ruth Ann, Horwitz, Ralph, Cutter, Gary, Tyry, Tuula

Polni tekst Polni tekst Polni tekst

Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree od Cutter, Gary R., Knappertz, Volker, Sasson, Nissim, Ladkani, David

Polni tekst Polni tekst Polni tekst

The Clinical Impact of Daptomycin Non-susceptible Enterococcus Bacteremia in Hematologic Malignancy od Lee, Rachael A, Kaye, Keith S, Cutter, Gary, Camins, Bernard

Polni tekst Polni tekst